secwatch.observer — SEC 8-K summary
======================================

Issuer:     Revolution Medicines, Inc. (RVMD)
CIK:        0001628171
Form:       8-K
Filed at:   2024-06-24T23:59:59+00:00
Accession:  0001193125-24-166939
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Revolution Medicines annual meeting votes approve all three proposals
---------------------------------------------------------------------

- Elected Class I directors: Elizabeth McKee Anderson (107.1M for), Flavia Borellini (107.3M for), Lorence Kim (97.4M for); broker non-votes 17.7M.
- Ratified PricewaterhouseCoopers as independent auditor for FY2024: 148.1M for, 9.9K against, 67.4K abstentions.
- Approved non-binding advisory vote on executive compensation: 128.9M for, 1.6M against, 27K abstentions; broker non-votes 17.7M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1628171/000119312524166939/0001193125-24-166939-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1628171/000119312524166939/d853953d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-166939

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer